Anemia after kidney transplantation: Time for action

Journal of the American Society of Nephrology

Volumn 17, Issue 11, 2006, Pages 2962-2963

  Augustine, Joshua J ^a   Hricik, Donald E ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; IRON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RECOMBINANT ERYTHROPOIETIN;

AGE; ANEMIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DRUG USE; EDITORIAL; ERYTHROID CELL; GENDER; GLUCOSE INTOLERANCE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IRON THERAPY; KIDNEY ALLOGRAFT REJECTION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MORTALITY; NEPHROTOXICITY; POSTTRANSPLANT ANEMIA; PREVALENCE; PRIORITY JOURNAL; RENAL PROTECTION; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 33750709677     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006090991     Document Type: Editorial

References (13)

1. Mix TC, Kazmi W, Khan S, Ruthazer R, Rohrer R, Pereira BJ, Kausz AT: Anemia: A continuing problem following kidney transplantation. Am J Transplant 3: 1426-1433, 2003
2. Yorgin PD, Belson A, Sanchez J, Al Uzri AY, Sarwal M, Bloch DA, Oehlert J, Salvatierra O, Alexander SR: Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 40: 1306-1318, 2002
3. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F: Prevalence and management of anemia in renal transplant recipients: A European survey. Am J Transplant 3: 835-845, 2003
4. Augustine JJ, Knauss TC, Schulak JA, Bodziak KA, Siegel C, Hricik DE: Comparative effects of sirolimus and mycophenolate mofetil on erythropoeisis in kidney transplant patients. Am J Transplant 4: 2001-2006, 2004
5. Hricik DE: Anemia after kidney transplantation-Is the incidence increasing? Am J Transplant 3: 771-772, 2003
6. Pirsch JD, Becker BN: Another cause of the same old problem. Am J Transplant 4: 1931-1932, 2004
7. Elhendy A, Modesto KM, Mahoney DW, Khandheria BK, Seward JB, Pellikka PA: Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol 41: 129-135, 2003
8. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38: 955-962, 2001
9. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28: 53-61, 1996
10. Panagiotis T, Vlagopoulos T, Tighiouart H, Weiner DE, Griffith J, Pettitt D, Salem DN, Levey AS, Sarnak MJ: Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: The impact of chronic kidney disease. J Am Soc Nephrol 16: 3402-3410, 2005
11. Meier-Kriesch HU, Baliga R, Kaplan B: Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 75: 1291-1295, 2003
12. Gupta M, Miller BA, Ahsan N, Ulsh PJ, Zhang MY, Cheung JY, Yang HC: Expression of angiotensin II type I receptor on erythroid progenitors of patients with posttransplant erythrocytosis. Transplantation 70: 1188-1194, 2000
13. Imoagene-Oyedeji AE, Rosas SE, Doyle AM, Goral S, Bloom RD: Posttransplantion anemia at 12 months in kidney transplant recipients treated with mycophenolate mofetil: Risk factors and implications for mortality. J Am Soc Nephrol 17: 3240-3247, 2006